$93.2 Million is the total value of AH Equity Partners LSV II, L.L.C.'s 4 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Robinhood Markets, Inc. | $78,823,459 | +19.3% | 8,117,761 | 0.0% | 84.56% | +5.1% | ||
| EQRx, Inc. | $9,700,000 | -21.1% | 5,000,000 | 0.0% | 10.40% | -30.5% | ||
| NAUT | Nautilus Biotechnology, Inc. | $3,755,873 | +53.9% | 1,355,911 | 0.0% | 4.03% | +35.7% | |
| Erasca, Inc. | $940,625 | -30.2% | 312,500 | 0.0% | 1.01% | -38.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Robinhood Markets, Inc. | 8 | Q3 2023 | 84.6% |
| EQRx, Inc. | 8 | Q3 2023 | 24.5% |
| Nautilus Biotechnology, Inc. | 8 | Q3 2023 | 5.4% |
| Erasca, Inc. | 8 | Q3 2023 | 2.6% |
View AH Equity Partners LSV II, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 4 | 2023-11-09 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 4 | 2023-01-05 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View AH Equity Partners LSV II, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.